✨ Free AI Report
Futura Medical Plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Futura Medical Plc
Company Research

Futura Medical Plc: Business Overview, Financials & Competitive Analysis

Futura Medical is a UK-based pharmaceutical company specializing in topical sexual health treatments. The company developed Eroxon, a topical gel for erectile dysfunction that received regulatory approval in the EU an...

Analyst-debate audio for Futura Medical Plc

AskCyborg analysts argue the bull and bear cases for Futura Medical Plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
2/ 10Challenged

Cyborg Score thesis

High-risk turnaround story dependent on new management successfully reversing commercialization failures of approved sexual...

Read the full analyst-debate transcript →
Industry Pharmaceutical - Sexual Health / Specialty Care
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Futura Medical Plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Futura Medical Plc Overview

Pro stress-test →

Futura Medical is a UK-based pharmaceutical company specializing in topical sexual health treatments. The company developed Eroxon, a topical gel for erectile dysfunction that received regulatory approval in the EU and US, and is pursuing additional indications including WSD4000 for female sexual dysfunction.

Strategic Profile

Pro stress-test →

Futura leverages proprietary DermaSys transdermal delivery technology for topically applied products. Despite securing commercial partnerships with Cooper Consumer Health (EU) and Haleon (US), the company has faced significant commercialization challenges, with Eroxon failing to achieve expected market traction despite regulatory wins.

Competitive Landscape

Pro stress-test →

Futura competes in the sexual health pharmaceutical market against established players and generic competitors. The company's topical approach differentiates from oral medications, but execution challenges have hampered competitive positioning. Key partnership relationships with Haleon and Cooper Consumer Health provide distribution but have not translated to commercial success.

Industry Context

Futura Medical Plc operates in Pharmaceutical - Sexual Health / Specialty Care.

Key facts

Founded: 2001 · Headquarters: Guildford, UK · Revenue: £1.3m - £1.4m (full year 2025 projection) · Market cap: £7.7m

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Futura Medical Plc.

  • Stock collapsed 96% in 2025 despite EU/US regulatory approvals for lead product Eroxon, signaling commercialization execution problems
  • H1 2025 sales of £1.0m vs £3.8m prior year; full-year projection at only £1.3-£1.4m indicates severe market adoption failure
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Trading statement revealed only £1.3-1.4m full year sales projection, well below expectations
  • Q3 2025Emergency fundraise of £2.75m due to severe cash constraints
  • +2 moreTrack every material event for Futura Medical Plc as it happens. Explore monitoring →
Get alerted when Futura Medical Plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Futura Medical Plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Futura Medical Plc operates in Pharmaceutical - Sexual Health / Specialty Care. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical - Sexual Health / Specialty Care research →
NEW · MCP server

Ask your AI assistant about Futura Medical Plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Futura Medical Plc and its top competitor on Cyborg Score”
“What did Futura Medical Plc do this quarter?”
“Is Futura Medical Plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Futura Medical Plc do?+
Futura Medical is a UK-based pharmaceutical company specializing in topical sexual health treatments. The company developed Eroxon, a topical gel for erectile dysfunction that received regulatory approval in the EU an...
What is Futura Medical Plc's Cyborg Score?+
Futura Medical Plc has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Futura Medical Plc's main competitors?+
Named competitors include Oral erectile dysfunction treatments, Topical ED products. The full competitive landscape is in the AskCyborg report.
How can I get the full Futura Medical Plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Futura Medical Plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Futura Medical Plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual